شنبه 1 دی 1403
[Archive]
دوره 30، شماره 142 - ( 7-1401 )
جلد 30 شماره 142 صفحات 451-443 |
برگشت به فهرست نسخه ها
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Soleimani M, Jalilvand A, Ahangar H. Epidemiological Characteristic and Spatial Analysis of the Admission Rate of Hypertension in Zanjan Province, Iran. J Adv Med Biomed Res 2022; 30 (142) :443-451
URL: http://journal.zums.ac.ir/article-1-6688-fa.html
URL: http://journal.zums.ac.ir/article-1-6688-fa.html
Epidemiological Characteristic and Spatial Analysis of the Admission Rate of Hypertension in Zanjan Province, Iran. Journal of Advances in Medical and Biomedical Research. 1401; 30 (142) :443-451
چکیده: (47032 مشاهده)
Background and Objective: hypertension is one of the most common global health problems and the leading cause of premature mortality worldwide. This study aims to investigate the epidemiological characteristic and the spatial-temporal variations of the admission rate of hypertension in Zanjan province, Iran, during 2014-2019.
Materials and Methods: Data were obtained from nine health information system (HIS) databases. Univariate chi-square and T-test methods were used to test the hypothesis, and binary logistic regression was used to model the probability of admission due to hypertension.
Results: Sixty-eight thousand eight hundred forty-three patients have been hospitalized due to cardiovascular diseases in Zanjan province, Iran, and 5931 cases had hypertension. The admission rate of hypertension was 555 cases per 100,000 which were higher in women than in males (755 cases vs. 357) (P<0.001). The highest admission rate of hypertension was detected in the age group over 80 and in Khoramdareh county, Zanjan province, Iran (P<0.001). The probability of admission due to hypertension was increased by aging in all regions, which was higher among women and in the Southeast study area.
Conclusion: This study shows the high admission rate of hypertension in Zanjan province, Iran, from 2014-2019. It is a warning to policymakers and local health authorities to increase their efforts to reduce the incidence of hypertension by identifying the principal main risk factors and applying periodic screening programs in high-risk, high areas.
نوع مطالعه: مقاله پژوهشی |
موضوع مقاله:
Epidemiologic studies
دریافت: 1400/6/6 | پذیرش: 1401/3/30 | انتشار: 1401/5/17
دریافت: 1400/6/6 | پذیرش: 1401/3/30 | انتشار: 1401/5/17
فهرست منابع
1. Mirzaei M, Bagheri B, Dehghani A. Awareness, treatment, and control of hypertension and related factors in adult Iranian population. BMC Public Health. 2020;20(1):667. [DOI:10.1186/s12889-020-08831-1] [PMID] [PMCID]
2. Tabrizi JS, Sadeghi-Bazargani H, Farahbakhsh M, Nikniaz L, Nikniaz Z. Prevalence and associated factors of prehypertension and hypertension in Iranian population: The lifestyle promotion project (LPP). PloS one. 2016;11(10):e0165264. [DOI:10.1371/journal.pone.0165264] [PMID] [PMCID]
3. Musaiger AO, Al-Hazzaa HM. Prevalence and risk factors associated with nutrition-related noncommunicable diseases in the Eastern Mediterranean region. Int J General Med. 2012;5:199-217. [DOI:10.2147/IJGM.S29663] [PMID] [PMCID]
4. Rubinstein AL, Irazola VE, Calandrelli M, et al. Prevalence, awareness, treatment, and control of hypertension in the southern cone of latin America. Am J Hypertens. 2016;29(12):1343-52. [DOI:10.1093/ajh/hpw092] [PMID] [PMCID]
5. Unwin N, Setel P, Rashid S, et al. Noncommunicable diseases in sub-Saharan Africa: where do they feature in the health research agenda? Bullet World Health Organ. 2001;79(10):947-53.
6. Wolf-Maier K, Cooper RS, Banegas JR, et al. Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States. JAMA. 2003;289(18):2363-9. [DOI:10.1001/jama.289.18.2363] [PMID]
7. Kearney PM, Whelton M, Reynolds K, Whelton PK, He J. Worldwide prevalence of hypertension: a systematic review. J Hypertension. 2004;22(1):11-9. [DOI:10.1097/00004872-200401000-00003] [PMID]
8. Haghdoost A, Sadeghirad B, Rezazadeh Kermani M. Epidemiology and heterogeneity of hypertension in Iran: A systematic review. Arch Iran Med. 2008;11:444-52.
9. Malekzadeh MM, Etemadi A, Kamangar F, et al. Prevalence, awareness and risk factors of hypertension in a large cohort of Iranian adult population. J Hypertension. 2013;31(7):1364-71 [DOI:10.1097/HJH.0b013e3283613053] [PMID] [PMCID]
10. Khajedaluee M, Hassannia T, Rezaee A, Ziadi M, Dadgarmoghaddam M. The prevalence of hypertension and its relationship with demographic factors, biochemical, and anthropometric indicators: A population-based study. ARYA Atheroscler. 2016;12(6):259-65.
11. Sahebi L, Vahidi R, Mousavi S. Prevalence of hypertension and associated variables in Hospital staff in Iran. Acta Medica Saliniana. 2010;39. [DOI:10.5457/ams.138.10]
12. Amiri P, Vahedi-Notash G, Naseri P, et al. National trends of pre-hypertension and hypertension among Iranian adolescents across urban and rural areas (2007-2011). Biol Sex Differ. 2019;10(1):15. [DOI:10.1186/s13293-019-0234-x] [PMID] [PMCID]
13. Afsargharehbagh R, Rezaie-Keikhaie K, Rafiemanesh H, Balouchi A, Bouya S, Dehghan B. Hypertension and pre-hypertension among Iranian adults population: a meta-analysis of prevalence, awareness, treatment, and control. Curr Hypertens Rep. 2019;21(4):27 [DOI:10.1007/s11906-019-0933-z] [PMID]
14. Zhao Y, Oldenburg B, Zhao S, Haregu TN, Zhang L. Temporal trends and geographic disparity in hypertension care in China. J Epidemiol. 2020;30(8):354-61. [DOI:10.2188/jea.JE20190029] [PMID] [PMCID]
15. Yin M, Augustin B, Fu Z, Yan M, Fu A, Yin P. Geographic distributions in hypertension diagnosis, measurement, prevalence, awareness, treatment and control rates among middle-aged and older adults in China. Sci Rep. 2016;6:37020. [DOI:10.1038/srep37020] [PMID] [PMCID]
16. Lunyera J, Kirenga B, Stanifer JW, et al. Geographic differences in the prevalence of hypertension in Uganda: Results of a national epidemiological study. PloS one. 2018;13(8):e0201001. [DOI:10.1371/journal.pone.0201001] [PMID] [PMCID]
17. Xu L, Jiang, Lairson D. Spatio-temporal variation of gender-specific hypertension risk: evidence from China. Int J Environment Res Public Health. 2019;16:4545. [DOI:10.3390/ijerph16224545] [PMID] [PMCID]
18. Piepoli MF, Hoes AW, Agewall S, et al. 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts)Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur Heart J. 2016;37(29):2315-81. [DOI:10.1093/eurheartj/ehw106] [PMID] [PMCID]
19. Wang Z, Du Q, Liang S, et al. Analysis of the spatial variation of hospitalization admissions for hypertension disease in Shenzhen, China. Int J Environment Res Public Health. 2014;11:713-33. [DOI:10.3390/ijerph110100713] [PMID] [PMCID]
20. Mills KT, Bundy JD, Kelly TN, et al. Global disparities of hypertension prevalence and control: A systematic analysis of population-based studies from 90 countries. Circulation. 2016;134(6):441-50. [DOI:10.1161/CIRCULATIONAHA.115.018912] [PMID] [PMCID]
21. Miranda M, Casper M, Tootoo J, Schieb L. Putting chronic disease on the map: building GIS capacity in state and local health departments. Prevent Chronic Disease. 2013;10:E100. [DOI:10.5888/pcd10.120321] [PMID] [PMCID]
22. Oori MJ, Mohammadi F, Norozi K, Fallahi-Khoshknab M, Ebadi A, Gheshlagh RG. Prevalence of HTN in Iran: meta-analysis of published studies in 2004-2018. Curr Hypertens Rev. 2019;15(2):113-22. [DOI:10.2174/1573402115666190118142818] [PMID] [PMCID]
23. Rajati F, Hamzeh B, Pasdar Y, et al. Prevalence, awareness, treatment, and control of hypertension and their determinants: Results from the first cohort of non-communicable diseases in a Kurdish settlement. Sci Rep. 2019;9(1):12409. [DOI:10.1038/s41598-019-48232-y] [PMID] [PMCID]
24. Khosravi A, Emamian MH, Shariati M, Hashemi H, Fotouhi A. The prevalence of pre-hypertension and hypertension in an Iranian urban population. High Blood Press Cardiovasc Prev . 2014;21(2):127-35. [DOI:10.1007/s40292-013-0035-y] [PMID]
25. Picon RV, Fuchs FD, Moreira LB, Riegel G, Fuchs SC. Trends in prevalence of hypertension in Brazil: a systematic review with meta-analysis. PloS one. 2012;7(10):e48255-e. [DOI:10.1371/journal.pone.0048255] [PMID] [PMCID]
26. Anchala R, Kannuri N, Pant H, et al. Hypertension in India: A systematic review and meta-analysis of prevalence, awareness, and control of hypertension. J Hypertens. 2014;36(2):1170-77 [DOI:10.1097/HJH.0000000000000146] [PMID] [PMCID]
27. Tripathy JP, Thakur JS, Jeet G, Chawla S, Jain S. Alarmingly high prevalence of hypertension and pre-hypertension in North India-results from a large cross-sectional STEPS survey. PloS one. 2017;12(12):e0188619-e. [DOI:10.1371/journal.pone.0188619] [PMID] [PMCID]
28. Hu L, Huang X, You C, et al. Prevalence and risk factors of prehypertension and hypertension in Southern China. PloS one. 2017;12:e0170238. [DOI:10.1371/journal.pone.0170238] [PMID] [PMCID]
29. Choi KM, Park HS, Han JH, et al. Prevalence of prehypertension and hypertension in a Korean population: Korean National Health and Nutrition Survey 2001. J Hypertens. 2006;24(8):1515-21. [DOI:10.1097/01.hjh.0000239286.02389.0f] [PMID]
30. Sarki AM, Nduka CU, Stranges S, Kandala N-B, Uthman OA. Prevalence of hypertension in low- and middle-income countries: A Systematic Review and Meta-Analysis. Medicine (Baltimore). 2015;94(50):e1959. [DOI:10.1097/MD.0000000000001959] [PMID] [PMCID]
31. Kearney P, Whelton M, Reynolds K, Muntner P, Whelton P, He J. Global burden of hypertension: analysis of worldwide data. Lancet. 2005;365:217-23. [DOI:10.1016/S0140-6736(05)17741-1]
32. Ong KL, Cheung BM, Man YB, Lau CP, Lam KS. Prevalence, awareness, treatment, and control of hypertension among United States adults 1999-2004. Hypertension (Dallas, Tex : 1979). 2007;49(1):69-75. [DOI:10.1161/01.HYP.0000252676.46043.18] [PMID]
33. Mirzaei M, Moayedallaie S, Jabbari L, Mohammadi M. Prevalence of hypertension in Iran 1980-2012: A Systematic Review. J Tehran Heart Cent. 2016;11(4):159-67.
34. Ebrahimi M, Mansournia MA, Haghdoost AA, et al. Social disparities in prevalence, treatment and control of hypertension in Iran: second national surveillance of risk factors of noncommunicable diseases, 2006. J Hypertens. 2010;28(8):1620-9. [DOI:10.1097/HJH.0b013e32833a38f2] [PMID]
35. Esteghamati A, Meysamie A, Khalilzadeh O, et al. Third national Surveillance of Risk Factors of Non-Communicable Diseases (SuRFNCD-2007) in Iran: methods and results on prevalence of diabetes, hypertension, obesity, central obesity, and dyslipidemia. BMC Public Health. 2009;9:167. [DOI:10.1186/1471-2458-9-167] [PMID] [PMCID]
| بازنشر اطلاعات | |
 |
این مقاله تحت شرایط Creative Commons Attribution-NonCommercial 4.0 International License قابل بازنشر است. |
